{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:14:29Z","timestamp":1791094469990,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2002,5,1]],"date-time":"2002-05-01T00:00:00Z","timestamp":1020211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,17]],"date-time":"2013-08-17T00:00:00Z","timestamp":1376697600000},"content-version":"vor","delay-in-days":4126,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2002,5]]},"DOI":"10.1067\/mva.2002.123093","type":"journal-article","created":{"date-parts":[[2002,10,9]],"date-time":"2002-10-09T17:24:11Z","timestamp":1034184251000},"page":"973-981","source":"Crossref","is-referenced-by-count":14,"title":["A chemically modified dextran inhibits smooth muscle cell growth in vitro and intimal in stent hyperplasia in vivo"],"prefix":"10.1067","volume":"35","author":[{"given":"Jean-Fran\u00e7ois","family":"Deux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Prigent-Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"d'Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent J.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmond","family":"Puvion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Logeart-Avramoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Pell\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank P.","family":"Boudgh\u00e8ne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Letourneur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mva.2002.123093_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis: an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1067\/mva.2002.123093_bib2","first-page":"43","article-title":"Factors controlling the development of arterial lesions after injury","volume":"86","author":"Reidy","year":"1992","journal-title":"Circulation"},{"key":"10.1067\/mva.2002.123093_bib3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/265625a0","article-title":"Suppression by heparin of smooth muscle cell proliferation in the injured arteries","volume":"265","author":"Clowes","year":"1977","journal-title":"Nature"},{"key":"10.1067\/mva.2002.123093_bib4","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1083\/jcb.109.6.3147","article-title":"Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells","volume":"109","author":"Castellot","year":"1989","journal-title":"J Cell Biol"},{"key":"10.1067\/mva.2002.123093_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ddr.430290209","article-title":"Pharmacological and mechanistic aspects concerning the use of heparin and \u03b2-cyclodextrin tetradecasulfate for the treatment of vascular restenosis","volume":"29","author":"Reilly","year":"1993","journal-title":"Drug Dev Res"},{"key":"10.1067\/mva.2002.123093_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jcp.1041380119","article-title":"Decreased susceptibility of cultured smooth muscle cells from SHR rats to growth inhibition by heparin","volume":"138","author":"Resink","year":"1989","journal-title":"J Cell Physiol"},{"key":"10.1067\/mva.2002.123093_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/jcp.1041240104","article-title":"Binding and internalization of heparin by vascular smooth muscle cells","volume":"124","author":"Castellot","year":"1985","journal-title":"J Cell Physiol"},{"key":"10.1067\/mva.2002.123093_bib8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1006\/abio.1997.2096","article-title":"Synthesis and characterization of highly sensitive heparin probes for detection of heparin-binding proteins","volume":"247","author":"Stearns","year":"1997","journal-title":"Anal Biochem"},{"key":"10.1067\/mva.2002.123093_bib9","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/jcp.1041650327","article-title":"Heparin binding, internalization, and metabolism in vascular smooth muscle cells: I. Upregulation of heparin binding correlates with antiproliferative activity","volume":"165","author":"Letourneur","year":"1995","journal-title":"J Cell Physiol"},{"key":"10.1067\/mva.2002.123093_bib10","first-page":"3707","article-title":"Heparin suppresses specific second messenger pathways for proto-oncogene expression in rat vascular smooth muscle cells","volume":"267","author":"Pukac","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1067\/mva.2002.123093_bib11","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1021\/bi00069a008","article-title":"Specificity in the interactions of extracellular matrix proteins with subpopulations of the glycosaminoglycan heparin","volume":"32","author":"San Antonio","year":"1993","journal-title":"Biochemistry"},{"key":"10.1067\/mva.2002.123093_bib12","first-page":"11075","article-title":"Competitive, reversible, and potent antagonism of inositol 1,4,5-trisphosphate-activated calcium release by heparin","volume":"263","author":"Ghosh","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1067\/mva.2002.123093_bib13","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0741-5214(92)90746-U","article-title":"Regulation of smooth muscle cell function by heparin","volume":"15","author":"Clowes","year":"1992","journal-title":"J Vasc Surg"},{"key":"10.1067\/mva.2002.123093_bib14","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1172\/JCI116085","article-title":"Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor","volume":"90","author":"Lindner","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1067\/mva.2002.123093_bib15","first-page":"19173","article-title":"Heparin inhibits mitogen-activated protein kinase activation in intact rat vascular smooth muscle cells","volume":"268","author":"Ottlinger","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1067\/mva.2002.123093_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/01.RES.81.1.17","article-title":"Diverse effects of heparin on mitogen-activated protein kinase-dependent signal transduction in vascular smooth muscle cells","volume":"81","author":"Daum","year":"1997","journal-title":"Circ Res"},{"key":"10.1067\/mva.2002.123093_bib17","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0741-5214(98)70326-X","article-title":"Heparin inhibits thrombin-induced mitogen-activated protein kinase signaling in arterial smooth muscle cells","volume":"27","author":"Hedin","year":"1998","journal-title":"J Vasc Surg"},{"key":"10.1067\/mva.2002.123093_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1083\/jcb.116.1.31","article-title":"Trans-repressor activity of nuclear glycosaminoglycans on fos and jun\/AP-1 oncoprotein mediated transcription","volume":"116","author":"Busch","year":"1992","journal-title":"J Cell Biol"},{"key":"10.1067\/mva.2002.123093_bib19","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/0735-1097(95)00277-4","article-title":"The subcutaneous heparin and angioplasty restenosis prevention (SHARP) trial. Results of a multicenter randomized trial investigating the effects of high dose unfractionated heparin on angiographic restenosis and clinical outcome","volume":"26","author":"Brack","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mva.2002.123093_bib20","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1161\/01.CIR.96.10.3396","article-title":"Effect of nadroparin, a low-molecular-weight heparin, on clinical and angiographic restenosis after coronary balloon angioplasty: the FACT study","volume":"96","author":"Lablanche","year":"1997","journal-title":"Circulation"},{"key":"10.1067\/mva.2002.123093_bib21","doi-asserted-by":"crossref","first-page":"11111","DOI":"10.1073\/pnas.96.20.11111","article-title":"Tissue concentration of heparin, not administered dose, correlates with the biological response of injured arteries in vivo","volume":"96","author":"Lovich","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1067\/mva.2002.123093_bib22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v17.i4.20","article-title":"Polysaccharides for vascular cell targeting","volume":"17","author":"Blondin","year":"2000","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1067\/mva.2002.123093_bib23","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0008-6363(00)00129-2","article-title":"Low density lipoproteins in human plasma make vascular smooth muscle cells resistant to growth inhibition by heparin","volume":"47","author":"Underwood","year":"2000","journal-title":"Cardiovasc Res"},{"key":"10.1067\/mva.2002.123093_bib24","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1163\/156856293X00104","article-title":"Antiproliferative capacity of synthetic dextrans on smooth muscle cell growth: the model of derivatized dextrans as heparin-like polymers","volume":"4","author":"Letourneur","year":"1993","journal-title":"J Biomater Sci Polym Ed"},{"key":"10.1067\/mva.2002.123093_bib25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/(SICI)1097-4636(199805)40:2<275::AID-JBM12>3.0.CO;2-P","article-title":"Fluorescent and radiolabeling of polysaccharides: binding and internalization experiments on vascular cells","volume":"40","author":"Prigent-Richard","year":"1998","journal-title":"J Biomed Mater Res"},{"key":"10.1067\/mva.2002.123093_bib26","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0092-8674(89)90100-1","article-title":"Direct activation of the serine\/threonine kinase activity Raf-1 through tyrosine phosphorylation by the PDGF \u03b2 receptor","volume":"58","author":"Morrison","year":"1989","journal-title":"Cell"},{"key":"10.1067\/mva.2002.123093_bib27","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1161\/01.CIR.101.8.908","article-title":"Interleukin-10 inhibits intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits","volume":"101","author":"Feldman","year":"2000","journal-title":"Circulation"},{"key":"10.1067\/mva.2002.123093_bib28","first-page":"13369","article-title":"Coordinate, biphasic activation of p44 mitogen-activated protein kinase and S6 kinase by growth factors in hamster fibroblasts. Evidence for thrombin-induced signals different from phosphoinositide turnover and adenylylcyclase inhibition","volume":"267","author":"Kahan","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1067\/mva.2002.123093_bib29","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1161\/01.RES.87.2.92","article-title":"Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor","volume":"87","author":"Kalmes","year":"2000","journal-title":"Circ Res"},{"key":"10.1067\/mva.2002.123093_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/(SICI)1097-4652(199604)167:1<8::AID-JCP2>3.0.CO;2-T","article-title":"Entry and distribution of fluorescent antiproliferative heparin derivatives into rat vascular smooth muscle cells: comparison between heparin-sensitive and heparin resistant cultures","volume":"167","author":"Barzu","year":"1996","journal-title":"J Cell Physiol"},{"key":"10.1067\/mva.2002.123093_bib31","first-page":"13575","article-title":"Transport of heparan sulfate into the nuclei of hepatocytes","volume":"261","author":"Ishihara","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1067\/mva.2002.123093_bib32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/jbm.10072","article-title":"Heparin and non heparin-like dextrans differentially modulate endothelial cell proliferation: in vitro evaluation with soluble and crosslinked polysaccharide matrices","volume":"60","author":"Letourneur","year":"2002","journal-title":"J Biomed Mater Res"},{"key":"10.1067\/mva.2002.123093_bib33","doi-asserted-by":"crossref","first-page":"39748","DOI":"10.1074\/jbc.M101117200","article-title":"VEGF165 activities are inhibited by carboxymethyl benzylamide dextran that competes for heparin binding to VEGF165 and VEGF165:KDR complexes","volume":"276","author":"Hamma-Kourbali","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1067\/mva.2002.123093_bib34","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0006-2952(99)00051-9","article-title":"Effects of the binding of a dextran derivative on fibroblast growth factor 2: secondary structure and receptor-binding studies","volume":"57","author":"Bittoun","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1067\/mva.2002.123093_bib35","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1124\/mol.56.1.204","article-title":"Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds","volume":"56","author":"Liekens","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1067\/mva.2002.123093_bib36","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1172\/JCI119319","article-title":"Modulation of fibroblast growth factor-2 receptor binding, dimerization, signaling, and angiogenic activity by a synthetic heparin-mimicking polyanionic compound","volume":"99","author":"Miao","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1067\/mva.2002.123093_bib37","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/1097-4644(20010401)81:1<114::AID-JCB1028>3.0.CO;2-Q","article-title":"A synthetic heparin-mimicking polyanionic compound binds to the LDL receptor-related protein and inhibits vascular smooth muscle cell proliferation","volume":"81","author":"Benezra","year":"2001","journal-title":"J Cell Biochem"},{"key":"10.1067\/mva.2002.123093_bib38","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/(SICI)1097-4652(199712)173:3<371::AID-JCP9>3.0.CO;2-K","article-title":"Heparin suppresses sgk, an early response gene in proliferating vascular smooth muscle cells","volume":"173","author":"Delmolino","year":"1997","journal-title":"J Cell Physiol"},{"key":"10.1067\/mva.2002.123093_bib39","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1152\/physrev.2001.81.3.999","article-title":"Vascular smooth muscle growth: autocrine growth mechanisms","volume":"81","author":"Berk","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1067\/mva.2002.123093_bib40","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1006\/jsre.2000.6014","article-title":"Effects of active and negative mutants of Ras on rat arterial neointima formation","volume":"94","author":"Jin","year":"2000","journal-title":"J Surg Res"},{"key":"10.1067\/mva.2002.123093_bib41","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/01.RES.79.5.1007","article-title":"Angiotensin II stimulates MAP Kinase kinase kinase activity in vascular smooth muscle cells","volume":"79","author":"Liao","year":"1996","journal-title":"Role of Raf. Circ Res"},{"key":"10.1067\/mva.2002.123093_bib42","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/01.CIR.78.3.646","article-title":"Intra-arterial stenting in the atherosclerotic rabbit","volume":"78","author":"Robinson","year":"1988","journal-title":"Circulation"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521402488751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521402488751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,15]],"date-time":"2019-12-15T23:01:03Z","timestamp":1576450863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521402488751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,5]]}},"alternative-id":["S0741521402488751"],"URL":"https:\/\/doi.org\/10.1067\/mva.2002.123093","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2002,5]]}}}